Á. Hernández-Bartolomé

Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C

J. Salmerón, L. Rodrigo, C. López-Larrea, 2017, PloS one.

Inhibition of Tyrosine Kinase Receptor Tie2 Reverts HCV-Induced Hepatic Stellate Cell Activation

R. Lopez-Rodriguez, F. Molina-Jiménez, P. Sanz-Cameno, 2014, PloS one.

Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study

R. Krüger, D. Buonsenso, M. Sali, 2022, Thorax.

Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C

R. Lopez-Rodriguez, M. Borque, P. Sanz-Cameno, 2011, Alimentary pharmacology & therapeutics.

Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy

L. Rodrigo, M. Borque, J. Salmerón, 2013, Genes and Immunity.

Intrahepatic angiopoietin‐2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems

M. Borque, P. Sanz-Cameno, L. González-Moreno, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Preliminary evidence of sustained expression of angiopoietin‐2 during monocyte differentiation in chronic hepatitis C

M. Borque, P. Sanz-Cameno, R. Moreno-otero, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Genetic Variants of Interferon‐Stimulated Genes and IL‐28B as Host Prognostic Factors of Response to Combination Treatment for Chronic Hepatitis C

J. Salmerón, M. Román, F. Abad‐Santos, 2011, Clinical pharmacology and therapeutics.

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C

M. Borque, P. Sanz-Cameno, L. González-Moreno, 2016, World journal of gastroenterology.

Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link

M. Borque, P. Sanz-Cameno, L. González-Moreno, 2013, PloS one.